Skip to main content

and
Your search also matched 6 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Final results of the department of defense multicenter breast lymphatic map** trial

Include preview-only content
  1. Article

    Open Access

    The Clinical Utility of DCISionRT® on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery

    The role of radiation therapy (RT) following breast-conserving surgery (BCS) in ductal carcinoma in situ (DCIS) remains controversial. Trials have not identified a low-risk cohort, based on clinicopathologic f...

    Chirag Shah MD, Troy Bremer PhD, Charles Cox MD in Annals of Surgical Oncology (2021)

  2. Article

    Correction to: The Clinical Utility of DCISionRT® on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery

    A correction to this paper has been published: https://doi.org/10.1245/s10434-021-10138-3

    Chirag Shah MD, Troy Bremer PhD, Charles Cox MD in Annals of Surgical Oncology (2021)

  3. Article

    Open Access

    The Predictive Utility of MammaPrint and BluePrint in Identifying Patients with Locally Advanced Breast Cancer Who are Most Likely to Have Nodal Downstaging and a Pathologic Complete Response After Neoadjuvant Chemotherapy

    Neoadjuvant chemotherapy (NCT) increases the feasibility of surgical resection by downstaging large primary breast tumors and nodal involvement, which may result in surgical de-escalation and improved outcomes...

    Peter Blumencranz MD, FACS, Mehran Habibi MD in Annals of Surgical Oncology (2023)